"atai Life Sciences Announces Pricing of $130 Million Common Stock Offering"

"atai Life Sciences has announced a registered underwritten offering of 23,725,000 common shares priced at $5.48 each, with an option for underwriters to purchase an additional 3,558,750 shares. The offering is set to close on October 20, 2025, pending customary conditions. Latham & Watkins is representing atai in this offering."

In the recent transaction involving atai Life Sciences, the law firm Latham & Watkins represented the company in a registered underwritten offering. The transaction entails atai Life Sciences pricing an offering of 23,725,000 common shares at a price of US$5.48 per share, with an option for underwriters to purchase an additional 3,558,750 common shares. The offering is expected to close on October 20, 2025, pending customary closing conditions. The legal team from Latham & Watkins includes partner Nathan Ajiashvili, associates Kaj Nielsen, Adam Picker, and Elana Cates, as well as counsel Irina Yevmenenko and associate Catriela Cohen, who provided advice on public company representation matters.

"atai Life Sciences Announces Pricing of $130 Million Common Stock Offering"

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads